Vanguard Asset Management’s MBX Biosciences MBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$992K Buy
16,927
+2,175
+15% +$136K ﹤0.01% 1860
2026
Q2
$814K Hold
14,752
– – ﹤0.01% 1988
2026
Q1
$440K Buy
+14,752
New +$502K ﹤0.01% 2153

Other funds holding MBX

Vanguard Asset Management's MBX Position: Q3 2026 in Review

Vanguard Asset Management increased its MBX Biosciences (MBX) stake by 15% in Q3 2026, buying an estimated $136K and bringing the position to 16,927 shares worth $992K. The position accounts for ﹤0.01% of the portfolio, ranked #1860.

Vanguard Asset Management first reported a position in MBX in Q1 2026 and has held it in 3 quarters since. 190 funds tracked by Wall St. Rank hold MBX as of Q3 2026.

  • Vanguard Asset Management held 16,927 shares of MBX Biosciences worth $992K as of Q3 2026.
  • Vanguard Asset Management bought 2,175 MBX Biosciences shares in Q3 2026, an estimated $136K.
  • MBX Biosciences made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #1860 holding.
  • Vanguard Asset Management first reported a position in MBX Biosciences in Q1 2026 and has held it in 3 quarters since.
  • 190 funds tracked by Wall St. Rank held MBX Biosciences as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.